Cite
HARVARD Citation
Morse, M. et al. (n.d.). Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients. Journal for immunotherapy of cancer. p. . [Online].